Various investigators have identified the major domain organization of LRRK2 (leucine-rich repeat kinase 2), which includes a GTPase ROC (Ras of complex proteins) domain followed by a COR (C-terminal of ROC) domain and a protein kinase domain. In addition, there are four domains composed of structural repeat motifs likely to be involved in regulation and localization of this complex protein. In the present paper, we report our bioinformatic analyses of the human LRRK2 amino acid sequence to predict the repeat size, number and likely boundaries for the armadillo repeat, ankyrin repeat, the leucine-rich repeat and WD40 repeat regions of LRRK2. Homology modelling using known protein structures with similar domains was used to predict structures, exposed residues and location of mutations for these repeat regions. We predict that the armadillo repeats, ankyrin repeats and leucine-rich repeats together form an extended N-terminal flexible 'solenoid'-like structure composed of tandem repeat modules likely to be important in anchoring to the membrane and cytoskeletal structures as well as binding to other protein ligands. Near the C-terminus of LRRK2, the WD40 repeat region is predicted to form a closed propeller structure that is important for protein complex formation.
Introduction
In 2004, two landmark reports first identified mutations in the large multi-domain LRRK2 (leucine-rich repeat kinase 2) as causing late-onset autosomal-dominant Parkinson's disease [1, 2] . Various investigations have also indicated the presence of armadillo, ankyrin and WD40 repeat regions in addition to the two catalytic domains, a ROC (Ras of complex proteins) GTPase and a protein kinase domain, which are separated by a COR (C-terminal of ROC) domain [3] . However, a detailed analysis of all of the repeat modules in LRRK2 is lacking. We have undertaken varied protein sequence bioinformatic analyses to predict the likely repeat lengths, number of repeat segments and likely boundaries for these modular domains. We then undertook homology modelling to predict the expected molecular shape and sites of several pathogenic mutations for the repeat domains. Figure 1 summarizes the predicted arrangement for the LRRK2 domains with approximate repeat lengths and number.
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Armadillo repeats form an extended super helix
Marín [4] characterized a block of LRRK2-specific repeats at the N-terminus. Our analysis suggests that these repeats are variants of the armadillo repeat structure. Following alignment of LRRK2 orthologues to select an LRRK2-consensus repeat sequence, we identified 13 putative armadillo-type repeats after application of the PSI-BLAST (position-specific iterative basic local alignment search tool). For LRRK2, we predict 13 tandem multiples of approximately 42 residues, similar to the well-characterized β-catenin 42-amino-acid repeats [5] (Figure 2A ). These repeats typically contain three α-helix segments as shown in Figure 2 : a short helix 1 followed by two longer helices. In β-catenin, helix 2 and helix 3 pack against each other in an antiparallel mode. These structurally conserved sequence-degenerate repeats are predicted to make up the largest LRRK2 domain of approximately 600 amino acids. Homology modelling indicates an extended super helix with a hydrophobic core ( Figure 3B ); based on elements of δ-catenin (PDB code 3L6X) and importin-α structures (PDB code 1EE4) [6, 7] . The Parkinson's disease E334K mutation occurs on a predicted extended loop between armadillo repeats 6 and 7 ( Figure 3B ). Like β-catenin, the LRRK2 armadillo domain is likely to have a shallow groove lined with positively charged residues, such as histidine residues from helix 2 and 3 of LRRK2 armadillo repeats.
Figure 1 Arrangement of LRRK2 domains
The predicted size and number of repeat subunits for repeat domains are summarized to scale. aa, amino acids; COR, C-terminal of ROC.
Figure 2 Structural sequence alignments for putative repeats of LRRK2 armadillo, ankyrin and LRR domains
Helix regions are shaded green, the β-strand region is shaded yellow and sites of Parkinson's disease mutations are boxed and in red text. (A) LRRK2 consensus compared with the armadillo repeat consensus [17] . (B) LRRK2 ankyrin consensus compared with consensus from ankyrinR [8] . (C) LRR domain alignment. The LRR consensus is shown at the bottom [12] ; LRR1 is longer than standard, and repeat 8 is shorter. The β-strand region is shaded yellow.
Ankyrin repeats form gently curved extended structures
Similar to cytoskeletal erythrocyte ankyrin, we predict the LRRK2 protein also contains a set of 33-amino-acid structural tandem repeats. Seven repeats were predicted with a profile hidden Markov model and PSI-BLAST using a set of known ankyrin domains ( Figure 2B ). The LRRK2 consensus repeat is compared with human ankyrinR consensus sequence described by Michaely et al. [8] (PDB code 1N11). Ankyrin domains are characterized by two antiparallel α-helices followed by a loop to form a gently curved structure. The predicted structure shown in Figure 3 (B) for the LRRK2 ankyrin domain is modelled after the ankyrin repeat domain of ribonuclease L (PDB code 1WDY) [9] . In this predicted structure, the Parkinson's disease-associated mutation R793M is exposed on the surface of this domain on helix 2 of the putative ankyrin repeat 4. Thus we predict that this mutation alters the surface charge of this domain. It is unclear whether this mutation affects the structural integrity and/or the protein-protein interaction ability of the putative ankyrin repeats domain of LRRK2.
LRRs (leucine-rich repeats) form horseshoe-shaped structures
LRRs commonly occur as tandem repeats of approximately 25 amino acids in length in multiples of 2-30 to form a solenoid/horseshoe-shaped structure as first shown for ribonuclease inhibitor [10] . For LRRK2, 14 LRRs of approximately 24 amino acids were predicted by conformity with the consensus sequence shown at the bottom of Figure 2 (C), and by profile analysis using a pool of 743 structurally verified LRR repeats (REP version 1.1 [11] ). A common feature is an 11-residue sequence (LXXLXLXXNXL) in which the leucine and asparagine residues may be replaced by other hydrophobic residues. Figure 3 (B) depicts a predicted structure of the LRR domain modelled after parts of the known structures with similar repeat lengths (PDB codes 1OGQ, 1ZIW and 2FT3). In this structure, the LRR domain contains 14 repeats, which are grouped into two modules. Module 1 and Module 2 formed by LRR1-LRR7 and LRR9-LRR14 respectively are linked together by a shorter LRR8. The putative N-terminally extended capping LRR1 is shown at the top of Figure 2(C) . In known structures, each LRR subunit contributes a β-strand at the concave face to form a curved β-sheet, whereas the convex face consists of a variety of secondary structures with α-helices and turns and connecting loops [12] . LRRK2 orthologue-conserved leucine repeat 'position 8' basic residues in LRR4 (Arg 1067 ) and LRR7 (Lys 1138 ) at the concave face are likely to be involved in functional ligand interactions. The LRR domain mutation R1067Q mapped to the putative LRR4 is predicted to alter the surface charge of the concave face in the predicted structure ( Figure 3B) .
A recent study of this LRR domain by Vancraenenbroeck et al. [13] also predicted 14 LRRs for this LRRK2 region with a similar structural repeat alignment and similar homology structural prediction.
WD40 repeat modules form closed β-sheet propeller-like structures
WD40 repeats are so-named after their common length of 40 residues and for containing an unusual tryptophanaspartic acid motif. They were first identified in LRRK2 by Paizán-Ruíz et al. [1] and Zimprich et al. [2] . Sequence alignment of LRRK2 with F-box/WD repeat-containing protein 7 facilitated prediction of seven WD40 repeats in LRRK2 ( Figure 3A) . A WD40 consensus sequence from Li and Roberts [14] is included below Figure 3(A) . These repeats of the standard 40-residue length are expected to adopt a closed formation of β-sheet structures arranged radially to comprise a propeller-like shape ( Figure 3B ). Each WD40 repeat generally forms four β-strands named A-D ( Figure 3B ). WD40 repeats generally occur as multiples of six or seven due to packing constraints of the closed structure. Several inserts were identified occurring between predicted β-strands, including an extended insert after WD40 repeat 5, which may form an exposed surface for protein interactions. Structural modelling of the LRRK2 WD40 repeat domain utilizing alignment with the F-box/WD40 repeat protein 7 (PDB code 2OVP) [15] is shown in Figure 3(B) . A similar structure was predicted by Jorgensen et al. [16] for this domain, which indicated a positively charged central cleft.
The Parkinson's disease mutations G2385R and T2356I were mapped to elements of WD40 β-sheet 5. These mutations may alter the LRRK2 interaction with other proteins, ligands or LRRK2 domains, or modify LRRK2 substrate recruitment or dimerization.
Conclusions
Detailed analysis of LRRK2 predicted repeat domains indicate that the protein is aptly named as 'leucine-rich' with the N-terminal half composed of armadillo, ankyrin and LRR modules all containing many hydrophobic leucine residues. These N-terminal repeats are anticipated to form an extended flexible structure with a hydrophobic core exhibiting likely membrane and cytoskeletal anchoring and regulatory functions. The WD40 repeat domain C-terminal to the catalytic domains may contribute to LRRK2 binding to other cellular proteins to form protein complexes and regulation of the catalytic activities of LRRK2. Homology modelling of repeat domains indicated that several pathogenic Parkinson's disease mutations may interfere with charge distribution on interaction surfaces. Testing the sequence-structure predictions described to date awaits experimentally determined structures of the LRRK2 domains to further improve understanding of LRRK2 molecular function and interactions.
